RecruitingNCT05645510

LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

Sponsor

University of Alberta

Enrollment

75 participants

Start Date

Nov 24, 2022

Study Type

OBSERVATIONAL

Conditions

Breast Cancer Ovarian Cancer Prostate Cancer Melanoma Cancer Multiple Myeloma Tyrosine Kinase Mutation Chronic Leukemia

Summary

People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study (called LONGEVITI) is following people who are taking long-term targeted cancer drugs to understand how living with ongoing cancer treatment affects daily life, quality of life, and overall health over time. It is an observational study — participants are not assigned any new treatment. **You may be eligible if...** - You are currently taking a chronic (long-term) targeted anti-cancer medication - You are willing to participate in follow-up assessments over time **You may NOT be eligible if...** - You are not taking a chronic targeted cancer therapy - You are unwilling to complete the study requirements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.